Corporate members
- Chang Gung Memorial Hospital, Taiwan
- Beijing Yiling Institute of Pharmaceutical R&D Co. Ltd.
- Capital Medical University
- Chengdu University of TCM
- China Medical University, Taiwan
- CMC Tasly Group BV, Amsterdam, The Netherlands
- Guangdong Provincial Hospital of Chinese Medicine, China
- PuraPharm
- Shanghai University of TCM
- Taiji Group
- Tianjin University of TCM
Databases and bioinformatics tools
- Phytochemical Databases of Chinese Herbal Constituents & Bioactive Plant Compounds with Known Target Specificities TCM Database paper - research from King's College London
- Phytochemical Informatics of Traditional Chinese Medicine & Therapeutic Relevance Chemiformatics paper - research from King's College London
- TCM-ID Database (Singapore) TCM-ID Database (Singapore)
- TCMGeneDIT Database (Taiwan) TCMGeneDIT Database (Taiwan)
- Virtual Screening of Chinese Herbs with Random Forest Chemiformatics paper - research from King's College London
- Web-based TCM Information database Traditional Chinese Medicine Information Database
Good practice guidelines
- MIAPapAE: Minimum Information About a Peptide Array Experiment Please also visit: http://journal.embnet.org/index.php/embnetjournal/article/view/250/715
- Wellcome Trust Guidelines on Good Research Practice
- GP-TCM Definition to Good Practice in TCM Research
- CIMR: Core Information for Metabolomics Reporting including a list of publications on technical details of metabolomics and chemical analysis
- European Charter for Researchers
- GP-TCM Checklist for Consistent and Acceptable Quality of Herbal Research Materials
- GP-TCM Good Practice Guidelines on Reviewing and Publishing Studies on Herbal Medicine, with Special Emphasis on Traditional Chinese Medicine and Chinese Materia Medica
- GP-TCM Guidelines for Randomized Controlled Trials Investigating Chinese Herbal Medicine (CHM) – Summary
- GP-TCM Guidelines for Randomized Controlled Trials Investigating Chinese Herbal Medicine (CHM) and a Summary to This Guideline
- GP-TCM Position on Good Practice in TCM Research
- MIAME: Minimum Information About a Microarray Experiment
- MIAPE: Minimum Information About a Proteomics Experiment including a 'parent' document laying out principles and a number of 'modules' (MS, MSI & GE, etc) each of which applies to a particular technology
- MIARE: Minimum Information About a RNAi Experiment
- MIBBI Bioscience Reporting Guidelines and Tools Some MIBBI guidelines of particular interest (MIQE, CIMR, MIAME, MIAPE, MIAPapAE and MIARE) are listed independently below. For a full range of MIBBI guidelines and tools, please visit
- MIQE: Minimum Information for Publication of Quantitative Real-Time PCR Experiments
- The European Agency for Safety and Health at Work Guidelines
- The Quest for Modernisation of TCM
Organisations
- U.S. Food and Drug Administration (FDA)
- British Pharmacological Society
- CAMbrella consortium EC - FP7 funded Coordination Action Project for complementary and alternative medicine
- Consortium for Globalisation of Chinese Medicine (CGCM)
- European Medicines Agency (EMA)
- International Society of Chinese Medicine
- International Society of Ethnopharmacology
- Medicines and Healthcare products Regulatory Agency (MHRA)
- Society for Medicinal Plant and Natural Product Research
- State Food and Drug Administration, P. R. China (SFDA)
- The International Society of Regulatory Toxicology & Pharmacology
Total Views 2,041 , Today Views 9